Found: 12
Select item for more details and to access through your institution.
End of induction positron emission tomography complete response (PET‐CR) as a surrogate for progression‐free survival in previously untreated follicular lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 2, p. 333, doi. 10.1111/bjh.18217
- By:
- Publication type:
- Article
Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4117, doi. 10.3390/cancers15164117
- By:
- Publication type:
- Article
Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 21, p. 7935, doi. 10.1002/cam4.3422
- By:
- Publication type:
- Article
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 457, doi. 10.1093/neuonc/noaa168
- By:
- Publication type:
- Article
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. e1009, doi. 10.1016/j.clml.2022.07.015
- By:
- Publication type:
- Article
Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
- Published in:
- Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 573, doi. 10.1007/s11060-019-03194-z
- By:
- Publication type:
- Article
Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.
- Published in:
- 2021
- By:
- Publication type:
- journal article